期刊
ORAL DISEASES
卷 29, 期 2, 页码 547-556出版社
WILEY
DOI: 10.1111/odi.13967
关键词
low-level light therapy; oral mucositis; oral squamous cell carcinoma; photobiomodulation therapy
This study evaluated the impact of photobiomodulation therapy (PBMT) in an oral squamous cell carcinoma (OSCC) patient-derived xenograft (OSCC-PDX) model. The results showed that PBMT did not affect tumor behavior. This is an important clinical outcome for assessing the safety of PBMT in cancer patients.
Background Photobiomodulation therapy (PBMT) is an effective method for the prevention of oral mucositis. However, the effects of PBMT on oral squamous cell carcinoma (OSCC) have not yet been fully elucidated. This study aimed to evaluate the impact of PBMT in an OSCC-patient-derived xenograft (OSCC-PDX) model. Methods BALB/c nude mice with OSCC-PDX models were divided into Control, without PBMT (n = 8); Immediate irradiation, PBMT since one week after tumor implantation (n = 6); and Late irradiation, PBMT after tumors reached 200 mm(3) (n = 6). OSCC-PDX were daily irradiated (660 nm; 100 mW; 6 J/cm(2); 0,2 J/point) for 12 weeks. The tumors were collected and submitted to volumetric, histological, immunohistochemistry, and cell cycle analysis. Results No significant differences in the volumetric measurements (p = 0.89) and in the histopathological grade (p > 0.05) were detected between the groups. The immunohistochemical analysis of Ki-67 (p = 0.9661); H3K9ac (p = 0.3794); and BMI1 (p = 0.5182), and the evaluation of the cell cycle phases (p > 0.05) by flow cytometry also did not demonstrate significant differences between the irradiated and non-irradiated groups. Conclusion In this study, PBMT did not impact the behavior of OSCC-PDX models. This is an important preclinical outcome regarding safety concerns of the use of PBMT in cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据